MedPath

Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment

Not Applicable
Not yet recruiting
Conditions
Rhegmatogenous Retinal Detachment
Interventions
Procedure: foldable capsular scleral buckling
Procedure: vitrectomy
Registration Number
NCT06610786
Lead Sponsor
Eye & ENT Hospital of Fudan University
Brief Summary

The objective of the study is to evaluate:

1. Safety and efficacy of a novel foldable capsular scleral buckle (FCSB) in scleral buckling for primary rhegmatogenous retinal detachment (RRD) of medium complexity.

2. Comparison between FCSB and pars plana vitrectomy in therapeutic effects and complications in the treatment of primary RRD of medium complexity.

Detailed Description

Pars plana vitrectomy (PPV) and scleral buckling (SB) are major choices in treating rhegmatogenous retinal detachment (RRD) of medium complexity. PPV is more prevailed since it improved internal search for breaks and elimination of vitreous traction. SB has unmatched advantages over PPV such as earlier rehabilitation, free from prolonged positioning, less complicated cataract or glaucoma. The novel foldable capsular scleral buckle (FCSB) can create a big bulge by pressing on the sclera and seal the break in bullous RRD without scleral drainage. In the study, differences of anatomic and functional results between PPV and FCSB in treating primary RRD of medium complexity are evaluated.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria

One or more retinal holes which cannot be treated sufficiently with a single silicon sponge or silicone band (e.g. large holes, multiple holes, multiple holes of varying anterior-posterior localisation, massive traction)

Exclusion Criteria

  1. simple rhegmatogenous retinal detachment which can be treated with a single silicon sponge or silicone band (e.g. single holes, no traction, limit retinal detachment)
  2. Complicated RRD, including macular hole within the arcade, PVR C or D, severe cataract, severe vitreous hemorrhage, unclear macular hole,
  3. Combined with other eye diseases that affect vision prognosis.
  4. History of other eye surgeries including cataract surgery.
  5. Presence of systemic diseases that may affect postoperative observation and follow-up.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FCSBfoldable capsular scleral bucklingUsing foldable capsular scleral buckle surgery to treat primary rhegmatogenous retinal detachment (RRD) of medium complexity
PPVvitrectomyUsing pars plana vitrectomy to treat primary rhegmatogenous retinal detachment (RRD) of medium complexity
Primary Outcome Measures
NameTimeMethod
anatomic success rateFrom enrollment to the end of treatment at 6 months

The success rate of retinal reattachment

metamorphopsiaFrom enrollment to the end of treatment at 6 months

metamorphopsia is measured by M chart

Visual ResultsFrom enrollment to the end of treatment at 6 months

Best-Corrected Visual Acuity, and is measured by Snellen Chart, EDTRS Chart and charts designed for people with low vision

Secondary Outcome Measures
NameTimeMethod
The number of surgeries that achieved successful final retinal reattachmentFrom enrollment to the end of treatment at 6 months

The number of surgeries the patient undergoes to achieve final retinal reattachment

Surgical ComplicationsFrom enrollment to the end of treatment at 6 months

Surgical Complications, included EOM dysfunction,Choroidal detachment,Clinical CME,Macular pucker,Postoperative IOP \>21 mmHg with medications

Trial Locations

Locations (1)

EyeEntFudan

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath